+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Seizure Drug"

From
From
From
From
From
Tuberous Sclerosis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Tuberous Sclerosis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Chronic Daily Headache Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Chronic Daily Headache Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Tay Sachs Disease Pipeline Analysis Report 2025 - Product Thumbnail Image

Tay Sachs Disease Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Infantile Spasm Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Infantile Spasm Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Epilepsy Therapeutics Market Report 2024-2034 - Product Thumbnail Image

Epilepsy Therapeutics Market Report 2024-2034

  • Report
  • February 2024
  • 213 Pages
  • Global
From
From
From
From
From
From
From
From
Loading Indicator

The Seizure Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Seizure Drugs are used to treat epilepsy, a neurological disorder characterized by recurrent seizures. These drugs work by reducing the frequency and severity of seizures, and can be administered orally, intravenously, or rectally. Commonly used Seizure Drugs include anticonvulsants, benzodiazepines, and barbiturates. Seizure Drugs are typically prescribed by neurologists and other healthcare professionals. The market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the Seizure Drug market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more